Skip to main content Skip to navigation Skip to mobile navigation Skip to accessibility tools

Switchboard0151 556 5000

24/7 hotline (treatment side-effects)
The Clatterbridge Cancer Centre NHS Foundation Trust

You can search our website using your chosen language.

Private care
Charity
  • Home
  • Patients and visitors
    • Patients and visitors
    • Treatment and care
      • Treatment and care
      • Treatments
      • Cancer types
      • Consultants
      • Your first visit
      • Hospital appointments
      • Video appointments
      • Inpatients
      • Health advice - eating well, exercise and cancer care
        • Health advice - eating well, exercise and cancer care
        • Physical activity and cancer care
        • Eating well and cancer care
      • Clinical trials
      • Visitors
      • Getting here
      • Isle of Man patients
      • Private and international patients
      • Advice and support
        • Advice and support
        • Interpreters and help with additional needs
        • Cancer information and support centres
        • Benefits advice
        • Arts programme
        • Chaplaincy
      • Feedback, compliments and complaints
      • Request your records (subject access requests)
        • Request your records (subject access requests)
        • Request your records - easy-read information
        • Subject Access Request Form
      • Referral and second opinion
      • Patient information leaflets
        • Patient information leaflets
        • Lung cancer nursing team
        • Radiotherapy
        • Contact x-ray brachytherapy for rectal cancer (Papillon)
        • You and your gastrostomy feeding tube
        • Insertion of a rectal spacer for radiotherapy
        • High Dose Rate (HDR) brachytherapy to the vaginal vault
        • Proton beam therapy to the eye
        • High Dose Rate (HDR) brachytherapy to the skin
        • High Dose Rate (HDR) brachytherapy for cancer of the cervix
        • Treatment of prostate cancer with high dose rate (HDR) brachytherapy
        • Treatment of prostate cancer with high dose rate (HDR) brachytherapy in combination with external beam radiotherpay (EBRT)
        • Immunotherapy
        • Nasogastric tube - Being discharged with a nasogastric tube
        • You and your Totally Implanted Vascular Access Device (TIVAD) - Portacath
        • You and your PICC line
        • Eating well and coping well with side-effects on a vegan diet
        • Low residue diet information
        • Adding extra nourishment to your food when you have diabetes
        • Eating well and coping well with side-effects
        • Proton beam therapy: Frequently asked questions and other useful information
        • Hepato-pancreato-biliary (HPB) nursing and support team
        • Arthralgia
        • Immune-related hepatitis
        • Skin care advice for patients on immunotherapy treatment
        • Infliximab - frequently asked questions
        • Cancer of Unknown Primary
        • Your nasogastric (NG) feeding tube and medication
        • Lymphoedema advice
        • What to do after an extravasation
        • Scalp cooling - a guide for patients
        • Breast cancer nursing team
        • Prostate cancer nursing and support team
        • Skin cancer nursing team
        • Upper gastrointestinal (UGI) nursing and support team
        • Teenage and Young Adult service
        • Choosing a wig
        • Your cancer treatment in your community
        • Liver surveillance service
        • Supported self management and patient-directed open access - MGUS
        • Sick day rules for people on basal bolus or pre-mixed insulin
        • Patient information for referral for consideration of SABR
        • Simple lymphatic drainage - head and neck
        • Advice to patients with a cardiac implantable electronic device – pacemakers or ICDS
        • How can we help? (Holistic Needs Assessment)
        • Pituitary and craniopharyngioma – radiotherapy
        • My Medical Record - information for patients
        • Lenalidomide (Revlimid) switch to generic equivalents
        • Lidocaine 2% mouthwash
      • Communicating with patients
    • Our hospitals
    • Our services
    • Consultants
    • Get involved
  • Research and innovation
    • Research and innovation
    • Research
      • Research
      • Welcome to research
      • Our research
      • Research sponsorship
      • Clinical trials
      • Meet the team
      • Research partnerships
      • Jargon buster
      • Biobank
      • Research Strategy
      • How you can get involved
      • Research passports, honorary research contracts and letters of access
      • Research news
    • Innovation
      • Innovation
      • Welcome to innovation
  • Work with us
    • Work with us
    • Vacancies
    • Recruitment - joining our team
    • Your career: Our recruitment pack
    • Staff benefits: why choose us
      • Staff benefits: why choose us
      • Staff networks
      • Staff Excellence Awards 2023
        • Staff Excellence Awards 2023
        • Staff Excellence Awards 2022
    • Roles and careers we offer
      • Roles and careers we offer
      • Healthcare science
      • Physiotherapy
    • Staff profiles
    • Staff bank
    • Living locally
    • Apprenticeships
    • Work experience
    • Volunteering
    • Get involved
    • Staff privacy notice
  • Professionals
    • Professionals
    • Education and training
      • Education and training
      • Clinical education courses
      • Clinical scientist training
      • Communication skills
      • FRCR Part 2b mock exam
      • Nursing career pathway
        • Nursing career pathway
        • Nursing career pathway and competency framework toolkit
      • Papillon
    • Clinical guidance
      • Clinical guidance
      • Acute oncology (AO) and CUP guidance
      • Immunotherapy guidance
      • Metastatic spinal cord compression (MSCC) guidance
      • Catheter and line care guidance
      • SACT protocols and guidance
        • SACT protocols and guidance
        • All protocols and guidance
        • Breast
        • CNS
        • Gastrointestinal
        • Germ cell
        • Gynaecological
        • Haematology
        • Head and neck
        • Lung
        • Miscellaneous
        • Renal
        • Sarcoma
        • Skin
        • Supportive therapies
        • Urology
      • Referring patients
      • Haemato-Oncology (haematology) clinical guidance
    • Work with us
  • About us
    • About us
    • Who we are
    • Vision and strategy
      • Vision and strategy
      • Vision, mission and values
      • Strategies and plans
        • Strategies and plans
        • Five Year Strategic Plan
        • Green Plan
        • Innovation Strategy
        • People Commitment
        • Patient Experience Commitment
        • Research Strategy
        • Quality Improvement and Learning Strategy
    • How we're run
      • How we're run
      • Trust Board
        • Trust Board
        • Trust Board meetings and papers
      • Procurement
      • Council of Governors
        • Council of Governors
        • Our governors
      • Membership of our Trust
    • Who we work with
    • How we're doing
      • How we're doing
      • Our reports and accounts
      • Care Quality Commission
      • Equality, diversity and inclusion
      • Achievements and accreditations
    • Our services
    • Our history
    • Publications and documents
    • Freedom of Information (FOI)
    • News
    • Get involved
  • Contact us
  • Clatterbridge Cancer Centre on Facebook
  • Clatterbridge Cancer Centre on Instagram
  • Clatterbridge Cancer Centre on X
  • Clatterbridge Cancer Centre on Youtube
  • Clatterbridge Cancer Centre on LinkedIn

All protocols and guidance

You are here:

  1. Home
  2. Professionals
  3. Clinical guidance
  4. SACT protocols and guidance
  5. All protocols and guidance

You are here:

  1. Professionals - SACT protocols
  2. Haematology
  3. Haematology – Lymphoma
Thumbnail Title
PDF file icon R-MAA - Rituximab, Methotrexate & Cytarabine Primary CNS Lymphoma
PDF file icon Rituximab-Polatuzumab-CHP Diffuse Large B Cell Lymphoma (DLBCL)
PDF file icon Brentuximab and Bendamustine (FOC) Relapsed NK T Cell Lymphoma
PDF file icon Brentuximab Monotherapy Grey Zone Lymphoma (Compassionate Use Scheme)
PDF file icon R-Bendamustine v2.0
PDF file icon ABVD + Rituximab Nodular Lymphocyte Prominent Hodgkin’s Lymphoma and Nodular Lymphocyte Prominent B-Cell Lymphoma
PDF file icon ABVD Hodgkin’s Lymphoma V2.0
PDF file icon Acalabrutinib (monotherapy) Chronic Lymphocytic Leukaemia Protocol V1.1
PDF file icon Alemtuzumab (Campath®) & IV Cladribine (Leustat) T-Cell Prolymphocytic Leukaemia (TPLL)
PDF file icon BeGev RR Hodgkin's Lymphoma
PDF file icon Brentuximab Monotherapy Grey Zone Lymphoma (Compassionate Use Scheme)
PDF file icon CHOP +- Rituximab v2.0
PDF file icon Ibrutinib (Compassionate Use) Mantle Cell Lymphoma (MCL)
PDF file icon BCHP v2.0
PDF file icon ICE +- Rituximab (INPATIENT) Relapsed or Refractory Lymphoma
PDF file icon ICE +- Rituximab (OUTPATIENT) Relapsed or Refractory Lymphoma
PDF file icon IGEV +- Rituximab Relapsed or Refractory Hodgkin's or Non-Hodgkin's Lymphoma
PDF file icon Obinutuzumab & Bendamustine - Previously Untreated & Relapsed or Refractory Follicular Lymphoma Protocol V1.0
PDF file icon Obinutuzumab & CHOP - Previously Untreated Follicular Lymphoma V1.0
PDF file icon Obinutuzumab and Venetoclax Chronic Lymphocytic Leukaemia Protocol V1.0
  • ← Previous page
  • Page 1
  • Page 2
  • Page 3
  • Page 4
  • Next page→

More in this section...

Breast

CNS

Gastrointestinal

Germ cell

Gynaecological

Haematology

Head and neck

Lung

Miscellaneous

Renal

Sarcoma

Skin

Supportive therapies

Urology

Last updated 11th March 2024

  • Aintree
    Telephone: 0151 556 5958
  • Liverpool
    Telephone: 0151 556 5000
  • Wirral
    Telephone: 0151 556 5000
  • Other clinics
    Telephone: 0151 556 5000
  • Paddington
    Telephone: 0151 556 5000
  • Clatterbridge Cancer Centre on Facebook
  • Clatterbridge Cancer Centre on Instagram
  • Clatterbridge Cancer Centre on X
  • Clatterbridge Cancer Centre on Youtube
  • Clatterbridge Cancer Centre on LinkedIn
  • Compliments and complaints
  • Vacancies
  • Accessibility statement
  • Privacy
  • Freedom of information
  • CQC rating

Accessibility tools

Text size:
Contrast:

Created by Frank Ltd.

Return to header
Last accessibility toolbar action: none available